Analyst Ratings for Progenics Pharmaceuticals (PGNX) [Neutrals]

PGNX Rating Summary

  |   Expand Research on PGNX
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 8 / 10   Percentile Rank: 82%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/8/2012 Lazard Capital N/A Downgrade Neutral
(Buy)
N/A
(N/A)
2.70
(4.10)
51.85% Details
8/30/2012 Stifel N/A New Coverage Hold
(N/A)
N/A
(N/A)
4.25
(4.10)
-3.53% Details
Like PGNX Ratings? Also take a look at

PGNX Ratings News